Amerikanische Gesellschaft für Hirudotherapie

Draft genome sequences of Hirudo medicinalis and salivary transcriptome of three closely related medicinal leeches

Genomics study published in BMC Genomics (2020)

Zuletzt aktualisiert: June 18, 2026Geprüft von: ASH Editorial Board
Research article — evidence reviewArticle reference
Evidence: Preclinical (animal)Genomik & ProteomikSpeichel-PharmakologieBabenko VV et al. · BMC genomics, 2020

Abstract

BACKGROUND: Salivary cell secretion (SCS) plays a critical role in blood feeding by medicinal leeches, making them of use for certain medical purposes even today. RESULTS: We annotated the Hirudo medicinalis genome and performed RNA-seq on salivary cells isolated from three closely related leech species, H. medicinalis, Hirudo orientalis, and Hirudo verbana. Differential expression analysis verified by proteomics identified salivary cell-specific gene expression, many of which encode previously unknown salivary components. However, the genes encoding known anticoagulants have been found to be expressed not only in salivary cells. The function-related analysis of the unique salivary cell genes enabled an update of the concept of interactions between salivary proteins and components of haemostasis. CONCLUSIONS: Here we report a genome draft of Hirudo medicinalis and describe identification of novel salivary proteins and new homologs of genes encoding known anticoagulants in transcriptomes of three medicinal leech species. Our data provide new insights in genetics of blood-feeding lifestyle in leeches.

Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.

Publication typeJournal Article
Indexed MeSH termsAnimalsAnticoagulantsGene Expression ProfilingGene Expression RegulationGenomeHirudo medicinalisLeechesProteomicsSalivaSalivary Proteins and Peptides

Zusammenfassung

Draft Hirudo medicinalis genome plus RNA-seq of H. medicinalis, H. orientalis and H. verbana salivary cells identified novel salivary components and new homologs of known anticoagulants.

Warum dies für die Hirudotherapie relevant ist

This study annotated a draft Hirudo medicinalis genome and performed RNA-seq on salivary cells from H. medicinalis, H. orientalis, and H. verbana, combining transcriptomics with proteomics to identify many previously unknown salivary components and new homologs of known anticoagulant genes, while noting that known anticoagulant genes are also expressed outside salivary cells. For ASH, this is highly relevant as a genomic/transcriptomic foundation for understanding blood-feeding genetics and discovering novel anticoagulant/anti-hemostatic proteins in medicinal leech saliva. Honest caveat: the work is molecular and descriptive; it does not functionally validate the novel proteins' bioactivity, therapeutic utility, or relevance to clinical hirudotherapy.

Zitation

Draft genome sequences of Hirudo medicinalis and salivary transcriptome of three closely related medicinal leeches.

Babenko VV et al. · BMC genomics, 2020

Verwandter klinischer Kontext

Zur ASH-Bibliothek hinzugefügt: May 27, 2026 · Letzte Aktualisierung der Website: June 18, 2026

Diese Website stellt Bildungsinformationen bereit und ist weder eine medizinische Beratung noch eine Diagnose oder Behandlungsempfehlung. Die medizinische Blutegeltherapie ist mit klinisch relevanten Risiken verbunden und sollte ausschließlich von qualifizierten Klinikerinnen und Klinikern unter institutionell genehmigten Protokollen durchgeführt werden. Die FDA-510(k)-Zulassung für medizinische Blutegel ist auf bestimmte Indikationen beschränkt; experimentelle und Off-Label-Diskussionen werden entsprechend gekennzeichnet. Für patientenspezifische Beratung wenden Sie sich an eine qualifizierte Gesundheitsfachkraft.